USAdvisors Wealth Management’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,687
Closed -$26K 138
2025
Q1
$26K Hold
10,687
0.01% 135
2024
Q4
$33K Hold
10,687
0.01% 136
2024
Q3
$24K Hold
10,687
0.01% 126
2024
Q2
$27K Buy
10,687
+449
+4% +$1.14K 0.01% 124
2024
Q1
$30K Buy
+10,238
New +$31.4K 0.01% 135

Other funds holding DRTS

USAdvisors Wealth Management's DRTS Position: Q2 2025 in Review

USAdvisors Wealth Management sold out of Alpha Tau Medical (DRTS) in Q2 2025, closing a stake of 10,687 shares — an estimated $26K sold.

USAdvisors Wealth Management first reported a position in DRTS in Q1 2024 and held it in 5 quarters. The position peaked at $33K in Q4 2024. 24 funds tracked by Wall St. Rank hold DRTS as of Q2 2025.

  • USAdvisors Wealth Management reported no remaining Alpha Tau Medical position as of Q2 2025 after selling out during the quarter.
  • USAdvisors Wealth Management sold 10,687 Alpha Tau Medical shares in Q2 2025, an estimated $26K.
  • USAdvisors Wealth Management first reported a position in Alpha Tau Medical in Q1 2024 and held it in 5 quarters.
  • USAdvisors Wealth Management's Alpha Tau Medical position peaked at $33K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2025.

Based on USAdvisors Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.